DNA probe: market approval/hybrid capture : HPV DNA test in France

Article Abstract:

Digene looks at the recent clearance of its HPV test for cervical cancer screening as an important opportunity for the company and a reaffirmation of the value of HPV testing wherever there is strong emphasis on women's health and cervical cancer screening.

Digene Corp.

---

Image analysis: PAPNET approval as primary screen device/ Canada

Article Abstract:

Developer of and marketer of medical and health-related technologies NetMed Inc. has reported that it's partner Neuromedical Systems Inc., licensor of the technology for NetMed's PAPNET has received approval for the system as a "primary screener" in Canada.

Canada, Alliances, partnerships, NetMed Inc., Neuromedical Systems Inc.

---

Bion Diagnostic Sciences: first cancer marker cleared for home use

Article Abstract:

Redmond, WA-based Bion Diagnostic Sciences Inc. received FDA clearance for the BTA stat test. The test detects recurrent bladder cancer and is available for home use by prescription.

Bion Diagnostic Sciences

Similar abstracts:

• Abstracts: Primary impressions: barriers to primary care may run deeper than you think. Caring for Ms. Little Saigon
• Abstracts: How to analyze a pharmaceutical company. Industry trends
• Abstracts: The implementation of business process reengineering in American and Canadian hospitals. Quality improvement: beyond the institution
• Abstracts: New promotional moves in the arthritic/analgesic market. Maintenance men. Props a plenty
• Abstracts: Increased capacity may exacerbate rationing problems: with applications to medical care. Specialized service offerings and patients' choice of hospital: the case of cardiac catheterization

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.